FENC Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Fennec Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 11.02 USD 4.45% Market Closed

Market Cap: $382.8m

F	Fennec Pharmaceuticals Inc NASDAQ:FENC	US
S	Shanghai Pharmaceuticals Holding Co Ltd F:S1R	CN
G	Greif Inc F:GR3	US
	Banco Bilbao Vizcaya Argentaria SA OTC:BBVXF	ES
F	Fresenius Medical Care AG & Co KGaA F:FME	DE
	RB Global Inc F:J1F	US

Profitability Summary

Fennec Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

92%

Strong 3Y Average Gross Margin

93%

Declining Gross Margin

94% > 92%

Negative Operating Margin

-14%

Negative 3Y Average Operating Margin

-56%

Operating Margin is Increasing

-755% > -14%

Negative Net Margin

-22%

Negative 3Y Average Net Margin

-68%

Net Margin is Increasing

-810% > -22%

Negative Free Cash Flow Margin

-28%

Negative 3Y Average Free Cash Flow Margin

-43%

Free Cash Flow Margin is Increasing

-645% > -28%

Negative ROE

-66%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-1 327%

ROIC is Increasing

-32 427% > -29%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.